This article was first written in 2022. Historical events and figures below retain their dates; they should not be read as a description of the present phase of the pandemic. The degu evidence has been updated to distinguish computer predictions, cell experiments and infection in a living animal.
Can SARS-CoV-2 affect a degu, and what precautions make sense if an owner has COVID-19? The answer requires attention to the strength of the evidence, without assuming either a proven degu transmission risk or complete safety.
Coronavirus, COVID-19 and variants

COVID-19 is the disease; SARS-CoV-2 is the virus that causes it. It belongs to the betacoronaviruses, a group containing viruses associated with different mammalian hosts, including bats, camels and other domestic animals. SARS-CoV and MERS-CoV are related human pathogens, not alternative names for COVID-19. The fact that a species carries another coronavirus does not establish susceptibility to SARS-CoV-2.
The first recognised outbreak was reported in Wuhan, China, in 2019, followed by worldwide spread. Related coronaviruses occur in bats, but this does not establish that the pandemic virus was known to circulate unchanged in a particular bat colony. The route of emergence has been investigated through direct zoonotic spillover, an intermediate animal host and a laboratory-associated scenario. The WHO’s 2025 assessment retained important uncertainties; an early hypothesis about pangolins should not be presented as a proven origin. Calling COVID-19 a pandemic describes its worldwide spread, as with other historical pandemics such as influenza, plague, cholera or HIV/AIDS; it does not make their transmission mechanisms identical.

As a virus replicates, genetic changes may arise. Some give rise to distinguishable variants within the same viral species. Most changes do not necessarily make a virus more dangerous, but some affect transmission, immune recognition or disease severity. Circulation provides opportunities for further evolution.
SARS-CoV-2 spreads chiefly through infectious respiratory particles, including aerosols in shared air. Ventilation, appropriate respiratory precautions and hand hygiene have different, complementary roles; coughing into an elbow or tissue alone does not remove the risk from a poorly ventilated room.
Useful information sources include the WHO coronavirus pages, WHO questions and answers, Santé publique France and Our World in Data. The original article also listed CovidTracker, which should be consulted with attention to the dates and coverage of its data.
Prevention and treatment are different
The original 2022 overview discussed vaccination, including mRNA, non-replicating viral-vector and inactivated-virus technologies, alongside public-health precautions. It also mentioned Paxlovid. An antiviral treatment for eligible human patients is not a general substitute for preventing transmission and must not be given to a pet without veterinary direction. Consult current official advice and a healthcare professional for personal treatment or vaccination decisions.

SARS-CoV-2 and other animals
Infection has been investigated in many mammals, including cats, dogs, rabbits, hamsters, mice, rats, ferrets and wildlife such as white-tailed deer and bank voles. Reports involving livestock, laboratory animals and pets must be read by species and method: a naturally infected animal, an experimentally inoculated animal and a susceptible cell culture are not equivalent. Cat-and-dog serological studies provide evidence of exposure, not proof that all pets are major sources of infection for people.

Transmission from people into animal populations raises questions about wildlife reservoirs and possible spillback. These concerns do not establish that every infection becomes a reservoir or that a new animal-associated variant will necessarily be more virulent.

Two historical examples cited in the original article deserve their dates. Danish mink-farm investigations in 2020 documented transmission involving people and mink, published by Hammer and colleagues in 2021. In Hong Kong in January 2022, a pet-shop hamster-associated outbreak led to culling and was investigated as animal-to-human transmission with subsequent human spread. This was not simply the culling of a single breeding farm. These examples show that cross-species transmission can occur in particular circumstances; they do not establish the same process in degus.
The article also discussed abandonment. A Europe 1 report published on 18 January 2022 quoted the SPA and reported a 56% increase in abandonment of “new companion animals” compared with 2019. This was a category-level historical figure, not a degu-specific rate or a current statistic. Fear of COVID-19 does not justify abandoning an animal.
What does the evidence show for degus?
A 2022 bioinformatics study by Sun and colleagues compared ACE2-related sequence and structural features across species, including degus, for viral forms including Wuhan and Delta, with further variant comparisons. Such modelling can generate hypotheses about susceptibility, but cannot establish infection, clinical disease or transmission in a living degu.
A 2023 study by Li and colleagues adds laboratory evidence: degu-derived heart, lung and kidney cell cultures showed moderate transduction by a pseudotyped virus bearing SARS-CoV-2 spike. This tests a stage of cell entry under experimental conditions. It is not a demonstration of natural infection, full-virus replication in a pet degu, or degu-to-human transmission.
The studies reviewed here therefore do not establish degus as a natural reservoir for humans. Equally, an absence of a documented natural transmission event is not proof of zero risk. Proportionate hygiene and reduced close contact during illness are sensible.
Everyday precautions

Keep rooms well ventilated without exposing animals to unsafe temperatures or escape hazards. The original French advice of opening windows for ten minutes every hour reflected guidance discussed at the time; it is not a guarantee of adequate ventilation in every room. Clean your hands before and after animal care, handle respiratory secretions hygienically and avoid coughing or sneezing towards the animals.
If you have COVID-19
- Ask a healthy person to provide the animals’ usual care where possible.
- Limit close face-to-face contact, kissing, cuddling and sharing food while you are ill; continue to meet all feeding, water, cleaning and medical needs.
- Wash hands before and after handling animals, food or equipment. Avoid coughing or sneezing on them.
- If you must provide care yourself, use appropriate personal respiratory precautions and keep contact brief. Do not put a mask on the animal or apply disinfectant to its coat.
- Avoid choosing the animal room as your place of isolation where another suitable room is available. Follow current local guidance on human contact and illness.
- If a degu becomes unwell, telephone the vet before attending and explain the symptoms and relevant exposure. Breathing difficulty or marked lethargy needs prompt assessment.
These measures protect animal welfare while acknowledging uncertainty. Do not give human COVID-19 medicines to a degu or assume that respiratory signs identify the cause without examination.
Sources
World Health Organization (n.d.). Coronavirus disease (COVID-19). Official public-health information. https://www.who.int/health-topics/coronavirus
World Health Organization, Scientific Advisory Group for the Origins of Novel Pathogens (2025). Independent assessment of the origins of SARS-CoV-2. Report published 27 June 2025. https://www.who.int/publications/m/item/independent-assessment-of-the-origins-of-sars-cov-2-from-the-scientific-advisory-group-for-the-origins-of-novel-pathogens
Centers for Disease Control and Prevention (n.d.). What You Should Know about COVID-19 and Pets. Official animal-contact guidance. https://www.cdc.gov/coronavirus/2019-ncov/animals/pets.html
Dileepan, M., et al. (2021). Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA. Virulence, 12(1), 1597–1609. https://doi.org/10.1080/21505594.2021.1936433
Hammer, A. S., et al. (2021). SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark. Emerging Infectious Diseases, 27(2), 547–551. https://doi.org/10.3201/eid2702.203794
Yen, H.-L., et al. (2022). Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study. The Lancet, 399(10329), 1070–1078. https://doi.org/10.1016/S0140-6736(22)00326-9
Sun, H., et al. (2022). Systematic Tracing of Susceptible Animals to SARS-CoV-2 by a Bioinformatics Framework. Frontiers in Microbiology, 13, 781770. https://doi.org/10.3389/fmicb.2022.781770
Li, M., et al. (2023). Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals. The ISME Journal, 17(4), 549–560. https://doi.org/10.1038/s41396-023-01368-2
Salle, L., & Faure, M. (2022). SPA : pourquoi le Covid a entraîné une hausse des abandons des animaux de compagnie. Europe 1, 18 January 2022; interview with the SPA president. https://www.europe1.fr/societe/les-centres-de-la-spa-en-etat-de-saturation-face-a-la-recrudescence-des-abandons-4088466
